[Form 4] NORTHROP GRUMMAN CORP /DE/ Insider Trading Activity

Rhea-AI Filing Summary

Northrop Grumman Corporation (NOC)11/24/2025. The transactions were sales of very small share amounts, with prices ranging from about $560.39 to $566.15 per share. All sales are marked as dispositions and were made in the open market.

The director conducted these trades under a pre-established Rule 10b5-1 trading plan adopted on August 23, 2025, which is designed to allow insiders to sell shares according to a preset schedule. Following these transactions, the reporting person directly beneficially owns 4,281 shares of Northrop Grumman common stock.

11/25/2025 - 12:46 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

WELSH MARK A III

(Last) (First) (Middle)

2980 FAIRVIEW PARK DRIVE

(Street)

FALLS CHURCH VA 22042

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
NORTHROP GRUMMAN CORP /DE/ [ NOC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
11/24/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	11/24/2025		S		1(1)	D	$560.39	4,377	D
Common Stock	11/24/2025		S		6(1)	D	$561.51(2)	4,371	D
Common Stock	11/24/2025		S		7(1)	D	$562.52(3)	4,364	D
Common Stock	11/24/2025		S		9(1)	D	$563.62(4)	4,355	D
Common Stock	11/24/2025		S		61(1)	D	$564.36(5)	4,294	D
Common Stock	11/24/2025		S		12(1)	D	$565.31(6)	4,282	D
Common Stock	11/24/2025		S		1(1)	D	$566.15	4,281	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 23, 2025.

2. Represents the weighted average sale price of $561.51 rounded to the nearest hundredth. The highest price at which the shares were sold was $561.68 and the lowest price at which the shares were sold was $561.31. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote in this Form 4.

3. Represents the weighted average sale price of $562.52 rounded to the nearest hundredth. The highest price at which the shares were sold was $562.86 and the lowest price at which the shares were sold was $562.16. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote in this Form 4.

4. Represents the weighted average sale price of $563.62 rounded to the nearest hundredth. The highest price at which the shares were sold was $563.87 and the lowest price at which the shares were sold was $563.01. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote in this Form 4.

5. Represents the weighted average sale price of $564.36 rounded to the nearest hundredth. The highest price at which the shares were sold was $564.97 and the lowest price at which the shares were sold was $564.08. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote in this Form 4.

6. Represents the weighted average sale price of $565.31 rounded to the nearest hundredth. The highest price at which the shares were sold was $565.76 and the lowest price at which the shares were sold was $565.02. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote in this Form 4.

Remarks:

	/s/ Jennifer C. McGarey, Attorney-in-Fact	11/25/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did the Northrop Grumman (NOC) director report in this Form 4?

The filing reports that a Northrop Grumman (NOC) director sold multiple small blocks of common stock in open-market transactions on 11/24/2025.

On what date did the reported Northrop Grumman (NOC) stock sales occur?

All of the reported transactions occurred on November 24, 2025, as shown in Table I of the Form 4.

At what prices did the Northrop Grumman (NOC) director sell shares?

The reported sales were executed at prices ranging from about $560.39 to $566.15 per share, with several weighted-average prices detailed in the footnotes.

How many Northrop Grumman (NOC) shares does the director own after these sales?

After the reported transactions, the director beneficially owns 4,281 shares of Northrop Grumman common stock with direct ownership.

Were the Northrop Grumman (NOC) insider sales made under a Rule 10b5-1 plan?

Yes. The explanation states that the sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 23, 2025.

Does this Form 4 involve any derivative securities of Northrop Grumman (NOC)?

No derivative transactions are reported. Table II for derivative securities is present but does not list any acquisitions or dispositions.

What role does the reporting person hold at Northrop Grumman (NOC)?

The reporting person is identified as a Director of Northrop Grumman Corporation, as indicated in the relationship section of the form.